retatrutide glp-1 gip glucagon receptor agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Retatrutide, a GIP, GLP-1 and

Conflict of interest: MEP serves on the data safety monitoring board for Fractyl, has received investigator-initiated research support from Dexcom, and is a consultant for Eiger, Hanmi, and MBX Pharmaceuticals

Our guides on foods to avoid on peptide therapy and best foods to eat on GLP-1 compounds provide specific dietary recommendations

Tirzepatide BNF NICE

[1] Liraglutide (Victoza, Saxenda): These formulations follow a 30-day rule after first use

Retatrutide is the latest research-frontier option

Neuropharmacology 157:107668 Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW (2018) Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses